Amgen
AMGN
436.36
+11.42
+2.69%
Amgen
US · AMGN
#91 by market cap
Listed 1970
436.36
+11.42
+2.69%
Live - 5344 symbols - heartbeat 481s ago
· 2026-10-20 10:50
About Amgen
Amgen is a biotechnology company that discovers, develops and markets therapeutics across a broad range of disease areas. William Bowes Jr., Franklin Johnson Jr., George Rathmann and Joseph Rubinfeld founded the company on April 8, 1980; it is headquartered in Thousand Oaks, California.
- Founded
- 1980
- CEO
- Mr. Robert A. Bradway
- Employees
- 31,500
- Headquarters
- Thousand Oaks, California, United States of America
- Fiscal year end
- 12-31
- Website
- amgen.com
Company profile
- Exchange
- US
- Symbol
- AMGN
- Market-cap rank
- #91
- Listing date
- 1970-01-01
- Market cap
- 235.91B
- Float cap
- 235.27B
- Shares out
- 540.63M
- Float shares
- 539.16M
Sectors & themes
Drug Manufacturers - General
CAR-T Therapy
Weight Loss Drugs
ARK Portfolio
Government Pension Fund of Norway
Global medical industry
Regular Savings Plan
Fractional Shares JP
Star Stocks
Quote time 2026-10-20 10:50:11 · For reference only, not investment advice and not tailored to your situation.
Amgen discussion 0 comments